Birthweight and its association with retinal vessel equivalents – Results from the population‐based German Gutenberg Health Study

Saved in:
Bibliographic Details
Published inActa ophthalmologica (Oxford, England) Vol. 99; no. 5; pp. e773 - e774
Main Authors Fieß, Achim, Ponto, Katharina A., Urschitz, Michael S., Nickels, Stefan, Schulz, Andreas, Münzel, Thomas, Wild, Philipp S., Beutel, Manfred E., Lackner, Karl J., Pfeiffer, Norbert, Schuster, Alexander K.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.08.2021
Subjects
Adolescent
Adult
Aged
Birth Weight
birthweight
Blood Pressure - physiology
central retinal arteriolar equivalent
Child
Child, Preschool
epidemiology
Female
Humans
Infant
Infant, Newborn
Male
Middle Aged
population‐based study
Prospective Studies
retinal vessel metrics
Retinal Vessels - diagnostic imaging
Young Adult
birthweight
epidemiology
central retinal arteriolar equivalent
retinal vessel metrics
population-based study
Online AccessGet full text

Cover

More Information
Bibliography:All authors: The Gutenberg Health Study is funded through the government of Rhineland‐Palatinate (‘Stiftung Rheinland‐Pfalz für Innovation’, contract AZ 961‐386261/733), the research programmes ‘Wissen schafft Zukunft’ and ‘Center for Translational Vascular Biology (CTVB)’ of the Johannes Gutenberg University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. Schuster AK holds the professorship for ophthalmic healthcare research endowed by ‘Stiftung Auge’ and financed by ‘Deutsche Ophthalmologische Gesellschaft’ and ‘Berufsverband der Augenärzte Deutschland e.V.’ Wild PS is funded by the Federal Ministry of Education and Research (BMBF 01EO1503) and he is PI of the German Center for Cardiovascular Research (DZHK). Pfeiffer N receives financial support by Novartis, Ivantis, Santen, Thea, Boehringer Ingelheim Deutschland GmbH & Co. KG, Alcon, Sanoculis. Beutel ME received speaker honorarium from Pfizer Deutschland GmbH, Shire Deutschland GmbH and currently receives research grants from the governments of Rhineland‐Palatinate and Nordrhein‐Westfalen, the German Association of Psychoanalysis and Psychotherapy (DGPT), the German Research Foundation, the German Ministry of Research, the German Cancer Aid and the European Union. Fieß A., Ponto KA., Schulz A., Urschitz MS., Nickels S., Münzel T., Lackner KJ.: none.
Boehringer Ingelheim, PHILIPS Medical Systems and Novartis Pharma provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the journal policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Financial disclosure/conflict of interest: Pfeiffer N receives financial support and grants from Novartis, Ivantis, Santen, Thea, Boehringer Ingelheim Deutschland GmbH & Co. KG, Alcon, and Sanoculis. Schuster AK received research funding from Allergan, Bayer Vital, Novartis, PlusOptix and Heidelberg Engineering. Nickels S received reimbursement of travel expenses from Heidelberg Engineering. Fieß A., Ponto KA., Schulz A., Urschitz MS., Münzel T., Beutel M., Lackner KJ.: none.
Correction added on 01 October 2020, after first online publication: Projekt Deal funding statement has been added.
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1755-375X
1755-3768
DOI:10.1111/aos.14637